Zhejiang Tianyu Pharmaceutical Co., Ltd. (SHE:300702)
China · Delayed Price · Currency is CNY 22.68
+0.66 (3.00%)
Sep 30, 2026, 3:04 PM CST
SHE:300702 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 90.54 | 139.71 | 55.94 | 27.36 | -118.87 | 204.68 |
Depreciation & Amortization | 371.91 | 356.85 | 333.82 | 305.13 | 254.94 | 193.42 |
Other Amortization | 3.31 | 3.31 | 2.13 | 1.73 | 1.04 | 0.56 |
Loss (Gain) From Sale of Assets | -0.98 | 0.43 | -0.72 | 0.03 | 0.02 | -0.06 |
Asset Writedown & Restructuring Costs | 10.56 | 5.51 | 2.67 | 2.09 | 8.21 | 46.49 |
Loss (Gain) From Sale of Investments | 4.47 | 6.45 | 30.4 | 62.69 | 59.65 | -52.72 |
Provision & Write-off of Bad Debts | -1.24 | 9.72 | -1.37 | 6.3 | -3.87 | - |
Other Operating Activities | 102.9 | 116.68 | 93.95 | 181.3 | 92.4 | 26.91 |
Change in Accounts Receivable | 62.61 | -167.82 | -363.45 | -242.68 | -269.46 | -315.07 |
Change in Inventory | 237.39 | 96.36 | -32.85 | -12.72 | -515.15 | -763.47 |
Change in Accounts Payable | 0.52 | -106.28 | 216.62 | -340.18 | 450.23 | 355.46 |
Change in Other Net Operating Assets | 3.99 | 6.24 | 5.77 | -34.67 | -2.46 | 40.51 |
Operating Cash Flow | 898.14 | 473.57 | 344.64 | -43.9 | -48.7 | -262.23 |
Operating Cash Flow Growth | 2526.81% | 37.41% | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Capital Expenditures | -308.45 | -357.77 | -168.95 | -316.81 | -527.01 | -736.39 |
Sale of Property, Plant & Equipment | 4.41 | 4.72 | 1.42 | 3.56 | 4.11 | 0.77 |
Cash Acquisitions | - | - | - | 0.35 | - | -5.64 |
Investment in Securities | -25 | -20 | -13.75 | 2.5 | 22.5 | -118.7 |
Other Investing Activities | 2.99 | 2.74 | -36.02 | -44.95 | -20.42 | 57.59 |
Investing Cash Flow | -326.05 | -370.31 | -217.3 | -355.35 | -520.82 | -802.37 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Long-Term Debt Issued | - | 2,116 | 1,897 | 2,184 | 1,409 | 837.47 |
Total Debt Issued | 1,826 | 2,116 | 1,897 | 2,184 | 1,409 | 837.47 |
Long-Term Debt Repaid | - | -2,187 | -1,869 | -1,690 | -752.92 | -495.14 |
Lease Payments | -9.88 | -10.95 | -11.48 | -10.32 | - | -5.88 |
Total Debt Repaid | -1,873 | -2,187 | -1,869 | -1,690 | -752.92 | -495.14 |
Net Debt Issued (Repaid) | -47.24 | -71.19 | 27.79 | 494.47 | 656.52 | 342.33 |
Repurchase of Common Stock | -157.29 | - | -27.79 | - | -58 | -0.24 |
Common Dividends Paid | -53.26 | -57.96 | -70.19 | -51.12 | -69.42 | -112.43 |
Other Financing Activities | 10.12 | 7.12 | 93.04 | -80 | -9.76 | - |
Financing Cash Flow | -247.67 | -122.03 | 22.85 | 363.35 | 519.34 | 229.67 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Foreign Exchange Rate Adjustments | -22.4 | -2.03 | 20.43 | -1.89 | 12.93 | -6.15 |
Net Cash Flow | 302.03 | -20.8 | 170.62 | -37.79 | -37.25 | -841.09 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Free Cash Flow | 589.69 | 115.8 | 175.69 | -360.71 | -575.71 | -998.62 |
Free Cash Flow Growth | - | -34.09% | - | - | - | - |
Free Cash Flow Margin | 17.89% | 3.78% | 6.68% | -14.27% | -21.59% | -39.24% |
Free Cash Flow Per Share | 1.73 | 0.34 | 0.50 | -1.05 | -1.65 | -2.88 |
Levered Free Cash Flow | 646.14 | 66.77 | 377.65 | -527.06 | -415.35 | -747.26 |
Unlevered Free Cash Flow | 670.77 | 93.73 | 411.44 | -495.87 | -394.2 | -737.06 |
Free Cash Flow After Leases | 579.81 | 104.85 | 164.21 | -371.03 | -575.71 | -1,004 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash Income Tax Paid | 37.95 | 14.06 | 5.3 | -32.25 | -286.68 | -54.41 |
Change in Working Capital | 316.66 | -165.09 | -172.19 | -630.52 | -342.22 | -681.5 |